Biolase, Inc. (BIOL) Financial Statements (2024 and earlier)

Company Profile

Business Address 27042 TOWNE CENTRE DRIVE
FOOTHILL RANCH, CA 92610
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 3843 - Dental Equipment and Supplies (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2023
MRQ
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments4,18129,97217,5645,7898,04411,645
Cash and cash equivalents4,18129,97217,5645,7898,04411,645
Restricted cash and investments  203312312312251
Receivables5,8414,2383,0598,76011,11210,124
Inventory, net of allowances, customer advances and progress billings15,88412,92911,15710,99512,24812,298
Inventory15,88412,92911,15710,99512,24812,298
Prepaid expense 662680947   
Other current assets 1,1661,332573   
Other undisclosed current assets1,225 1,4981,1631,5911,732
Total current assets:28,95949,35435,11027,01933,30736,050
Noncurrent Assets
Operating lease, right-of-use asset1,7681,7171,976276
Property, plant and equipment4,2781,0677821,1931,9753,674
Intangible assets, net (including goodwill)2,9262,9262,9262,9262,9262,926
Goodwill2,9262,9262,9262,9262,9262,926
Other noncurrent assets255220231433308334
Total noncurrent assets:9,2275,9305,9154,8285,2096,934
TOTAL ASSETS:38,18655,28441,02531,84738,51642,984
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities14,99611,5859,31810,07613,49110,718
Accounts payable5,7863,3092,6515,3325,9535,109
Accrued liabilities9,2108,2766,6674,7447,5385,609
Deferred revenue2,1112,2591,9052,237
Debt700  13,466  
Deferred revenue and credits2,625
Customer advances and deposits27
Contract with customer, liability2,476
Total current liabilities:17,80713,84411,22325,77915,96713,370
Noncurrent Liabilities
Long-term debt and lease obligation13,09115,05217,960310,836 
Long-term debt, excluding current maturities13,09113,60316,186 10,836 
Liabilities, other than long-term debt2,3991,1801,8141,648547250
Deferred revenue and credits11
Accounts payable and accrued liabilities36052138424544770
Deferred revenue418329374358
Other liabilities3623301,0561,045100169
Operating lease, liability1,2591,4491,7743
Other undisclosed noncurrent liabilities    7577104
Total noncurrent liabilities:15,49016,23219,7741,72611,460354
Total liabilities:33,29730,07630,99727,50527,42713,724
Temporary equity, carrying amount 25,208 3,965  
Equity
Equity, attributable to parent4,88925,20810,02837711,08929,260
Preferred stock  34118   
Common stock8154983121102
Additional paid in capital301,782293,177261,573235,594228,430224,910
Accumulated other comprehensive loss(733)(623)(385)(701)(670)(576)
Accumulated deficit(296,168)(267,534)(251,376)(234,547)(216,692)(195,176)
Other undisclosed equity  (25,208)    
Total equity:4,889 10,02837711,08929,260
TOTAL LIABILITIES AND EQUITY:38,18655,28441,02531,84738,51642,984

Income Statement (P&L) ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Revenues48,46239,18822,78037,79946,15546,926
Revenue, net46,926
Cost of revenue(32,551)(22,659)(16,607)(23,511)(29,260)(31,800)
Gross profit:15,91116,5296,17314,28816,89515,126
Operating expenses(41,249)(32,960)(24,709)(29,909)(37,780)(33,164)
Operating loss:(25,338)(16,431)(18,536)(15,621)(20,885)(18,038)
Nonoperating income (expense)(3,187)(338)1,835(2,278)(568)605
Investment income, nonoperating  4,215   
Gain (loss), foreign currency transaction, before tax(438)452(21)(121)(58)563
Interest and debt expense 3,014(331)(188)(126) 
Other undisclosed income from continuing operations before equity method investments, income taxes      
Loss from continuing operations before equity method investments, income taxes:(28,525)(13,755)(17,032)(18,087)(21,579)(17,433)
Other undisclosed income (loss) from continuing operations before income taxes (2,338)331188126 
Loss from continuing operations before income taxes:(28,525)(16,093)(16,701)(17,899)(21,453)(17,433)
Income tax expense (benefit)(109)(65)(128)44(63)582
Loss from continuing operations:(28,634)(16,158)(16,829)(17,855)(21,516)(16,851)
Loss before gain (loss) on sale of properties:(16,158)(16,829)(17,855)(21,516)(16,851)
Net loss attributable to parent:(28,634)(16,158)(16,829)(17,855)(21,516)(16,851)
Preferred stock dividends and other adjustments  (546)(17,378)  (3,978)
Other undisclosed net loss available to common stockholders, basic (217)     
Net loss available to common stockholders, diluted:(28,851)(16,704)(34,207)(17,855)(21,516)(20,829)

Comprehensive Income ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Net loss:(28,634)(16,158)(16,829)(17,855)(21,516)(16,851)
Comprehensive loss:(28,634)(16,158)(16,829)(17,855)(21,516)(16,851)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(110)(238)316(31)(94)300
Comprehensive loss, net of tax, attributable to parent:(28,744)(16,396)(16,513)(17,886)(21,610)(16,551)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: